Research Information System
İstanbul Medical Journal, vol.26, no.1, pp.47-52, 2025 (ESCI, TRDizin)
Introduction: This study aimed to evaluate the diagnostic distribution, demographic characteristics, and medication adherence of elderly patients with rheumatic diseases (RD) and to contribute to improving adherence rates and patient outcomes in this demographic group by examining the factors affecting treatment adherence. Methods: This cross-sectional observational study included 108 patients aged >65 years diagnosed with RD. Data on demographic characteristics, disease characteristics, comorbidities, and medication use were collected. Medication adherence was assessed using the Morisky Medication Adherence Scale-8 and the Hospital Anxiety and Depression Scale (HADS) to assess anxiety and depression levels. Results: The median age of the participants was 70.5 years, with 69.4% female predominance. The most common diagnoses were rheumatoid arthritis (41.67%), gout (14.81%), and polymyalgia rheumatica (11.11%). Good adherence was associated with higher social support [odds ratio (OR): 4.99, 95% confidence interval (CI): 1.45-17.11], lower medication count (OR: 0.78, 95% CI: 0.63-0.95), and lower HADS scores (OR: 0.93, 95% CI: 0.87-0.98). Forgetfulness was the leading cause of non-adherence, as reported by 40.7% of patients. Conclusion: This study highlights that social support, polypharmacy, and mental health significantly affect medication adherence in elderly patients with RD. Medication adherence remains an important factor in the effective management of RD, and demographic factors, such as comorbidities and socioeconomic status, play influential roles.